FDA.reportPublic FDA data

2.4 ML Zepbound 20.8 MG/ML Pen Injector

RxCUI
2734634
RxNorm name
2.4 ML Zepbound 20.8 MG/ML Pen Injector
Display name
2.4 ML Zepbound 20.8 MG/ML Pen Injector
Full name
2.4 ML Zepbound 20.8 MG/ML Pen Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
487cd7e7-434c-4925-99fa-aa80b1cc776b2.4 ML Zepbound 20.8 MG/ML Pen InjectorSY38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
487cd7e7-434c-4925-99fa-aa80b1cc776bZepbound 50 MG per 2.4 ML Pen InjectorSY38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
487cd7e7-434c-4925-99fa-aa80b1cc776bzepbound 12.5 MG per dose (50 MG in 2.4 ML) Pen InjectorPSN38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
487cd7e7-434c-4925-99fa-aa80b1cc776b2.4 ML tirzepatide 20.8 MG/ML Pen Injector [Zepbound]SBD38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422